Expert panel cites safety risks of FDC medicines in toddlers

A committee of pediatric pharmacologists warned that fixed‑dose combinations of chlorpheniramine maleate and phenylephrine hydrochloride pose serious safety risks for children younger than four, recommending an immediate nationwide ban and mandatory warning labels.